Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant enterococcus faecium infections in liver transplant recipients; A reply to Lewis et al

Transpl Infect Dis. 2018 Dec;20(6):e13004. doi: 10.1111/tid.13004. Epub 2018 Oct 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Daptomycin*
  • Enterococcus faecium*
  • Humans
  • Liver Transplantation
  • Risk Factors
  • Vancomycin

Substances

  • Vancomycin
  • Daptomycin